VIVOBIOT · Vivo Bio Tech Limited · Financials
Market Cap
365.26M INR
Shares
22.19M
Volume · Nov 13
69.57K
Avg daily vol (3M)
32.16K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.
Revenue
533.35M
+14.3%
FY2026
Net Income
-17.09M
-123.5%
FY2026
Operating Cash Flow
349.31M
+195.3%
FY2026
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2026 | FY2025 |
|---|---|---|---|
| INR | 591.85M | 533.35M | 466.73M |
| INR | 126.96M | 106.27M | 90.17M |
| INR | 61.32M | 58.49M | 75.04M |
| INR | 40.29M | 48.1M | 87.93M |
| INR | 66.54M | 65.19M | 15.1M |
| INR | -26.25M | -17.09M | 72.83M |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2025–FY2026: 0 in dividends.
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.